Pcr-Dx, LLC

Pcr-Dx, LLC was paid $120K by Medicaid between Sep 2020 and Nov 2022, across 7 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 76% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2020	360	$16K
2021	2,157	$85K
2022	505	$18K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	76%	1,870	1,452	$91K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	11%	809	651	$13K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	6.7%	54	43	$8K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	4.0%	49	38	$5K
87581		1.0%	86	67	$1K
87640		1.0%	87	68	$1K
87486		<1%	67	50	$896.78

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLILLY, ROBERT (CFO)